Kelly Doran
Concepts (481)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Streptococcal Infections | 56 | 2026 | 168 | 19.440 |
Why?
| | Streptococcus agalactiae | 68 | 2026 | 108 | 19.190 |
Why?
| | Vagina | 24 | 2026 | 201 | 8.220 |
Why?
| | Bacterial Proteins | 39 | 2026 | 955 | 4.620 |
Why?
| | Meningitis, Bacterial | 17 | 2023 | 45 | 4.270 |
Why?
| | Blood-Brain Barrier | 20 | 2023 | 155 | 4.260 |
Why?
| | Virulence | 26 | 2026 | 278 | 3.940 |
Why?
| | Bacterial Adhesion | 19 | 2026 | 109 | 2.710 |
Why?
| | Type VII Secretion Systems | 5 | 2024 | 7 | 2.620 |
Why?
| | Adhesins, Bacterial | 12 | 2026 | 46 | 2.480 |
Why?
| | Brain | 20 | 2023 | 2933 | 1.990 |
Why?
| | Wound Infection | 3 | 2026 | 56 | 1.860 |
Why?
| | Microbial Interactions | 3 | 2026 | 19 | 1.830 |
Why?
| | Mice | 64 | 2026 | 18339 | 1.740 |
Why?
| | Premature Birth | 4 | 2022 | 380 | 1.670 |
Why?
| | Host-Pathogen Interactions | 10 | 2024 | 371 | 1.510 |
Why?
| | Glycolipids | 5 | 2026 | 52 | 1.490 |
Why?
| | Vimentin | 3 | 2022 | 54 | 1.440 |
Why?
| | Animals | 75 | 2026 | 38058 | 1.440 |
Why?
| | Community-Institutional Relations | 3 | 2021 | 101 | 1.420 |
Why?
| | Meninges | 4 | 2026 | 49 | 1.370 |
Why?
| | Disease Models, Animal | 24 | 2026 | 4557 | 1.310 |
Why?
| | Endothelium, Vascular | 9 | 2019 | 965 | 1.300 |
Why?
| | Fimbriae, Bacterial | 6 | 2020 | 36 | 1.270 |
Why?
| | Staphylococcus aureus | 5 | 2026 | 455 | 1.190 |
Why?
| | Antigens, Bacterial | 3 | 2019 | 125 | 1.150 |
Why?
| | Neutrophils | 13 | 2026 | 1134 | 1.130 |
Why?
| | Endothelial Cells | 12 | 2026 | 869 | 1.130 |
Why?
| | Gene Expression Regulation, Bacterial | 14 | 2026 | 327 | 1.100 |
Why?
| | Methicillin-Resistant Staphylococcus aureus | 4 | 2025 | 248 | 1.100 |
Why?
| | Chemokines | 4 | 2022 | 218 | 0.980 |
Why?
| | Streptococcus | 4 | 2022 | 29 | 0.960 |
Why?
| | Humans | 102 | 2026 | 144759 | 0.960 |
Why?
| | Fimbriae Proteins | 4 | 2013 | 25 | 0.960 |
Why?
| | Candida albicans | 1 | 2026 | 61 | 0.950 |
Why?
| | Skin | 3 | 2026 | 755 | 0.950 |
Why?
| | Bacterial Toxins | 5 | 2024 | 109 | 0.930 |
Why?
| | Malassezia | 1 | 2025 | 5 | 0.910 |
Why?
| | Mycobiome | 1 | 2025 | 9 | 0.900 |
Why?
| | Reproductive Health | 1 | 2026 | 91 | 0.890 |
Why?
| | Lactoylglutathione Lyase | 1 | 2025 | 19 | 0.890 |
Why?
| | Pyruvaldehyde | 1 | 2025 | 50 | 0.850 |
Why?
| | Diabetes Complications | 1 | 2026 | 222 | 0.850 |
Why?
| | Cell Line | 19 | 2020 | 2882 | 0.850 |
Why?
| | Leukocyte L1 Antigen Complex | 2 | 2022 | 40 | 0.840 |
Why?
| | Microbiota | 4 | 2026 | 781 | 0.820 |
Why?
| | Communicable Diseases | 1 | 2026 | 163 | 0.810 |
Why?
| | Female | 49 | 2026 | 78271 | 0.800 |
Why?
| | Teichoic Acids | 3 | 2025 | 18 | 0.780 |
Why?
| | Meningitis, Pneumococcal | 2 | 2014 | 7 | 0.760 |
Why?
| | Protein Kinases | 3 | 2016 | 315 | 0.760 |
Why?
| | Diabetes Mellitus, Experimental | 2 | 2025 | 198 | 0.760 |
Why?
| | Endothelium | 2 | 2021 | 119 | 0.760 |
Why?
| | Virulence Factors | 9 | 2025 | 172 | 0.760 |
Why?
| | Gene Expression Regulation | 6 | 2021 | 2608 | 0.760 |
Why?
| | Mutation | 18 | 2026 | 4089 | 0.740 |
Why?
| | Vulnerable Populations | 2 | 2020 | 177 | 0.740 |
Why?
| | Bacterial Outer Membrane Proteins | 1 | 2023 | 61 | 0.730 |
Why?
| | Membrane Lipids | 1 | 2023 | 83 | 0.730 |
Why?
| | Milk, Human | 2 | 2022 | 172 | 0.730 |
Why?
| | Bacillus anthracis | 3 | 2011 | 13 | 0.720 |
Why?
| | Manganese | 1 | 2022 | 55 | 0.720 |
Why?
| | Chorioamnionitis | 1 | 2022 | 45 | 0.720 |
Why?
| | Fibrinogen | 4 | 2019 | 177 | 0.700 |
Why?
| | Pregnancy | 11 | 2026 | 7190 | 0.700 |
Why?
| | Enterococcus faecalis | 2 | 2024 | 28 | 0.700 |
Why?
| | Nod2 Signaling Adaptor Protein | 1 | 2021 | 34 | 0.680 |
Why?
| | Practice Patterns, Nurses' | 1 | 2021 | 20 | 0.680 |
Why?
| | Zinc | 2 | 2022 | 295 | 0.670 |
Why?
| | Anthrax | 2 | 2011 | 9 | 0.650 |
Why?
| | Community Health Nursing | 1 | 2020 | 63 | 0.640 |
Why?
| | Minority Groups | 3 | 2021 | 282 | 0.640 |
Why?
| | Hemolysin Proteins | 7 | 2012 | 36 | 0.620 |
Why?
| | Gram-Positive Bacterial Infections | 1 | 2020 | 69 | 0.610 |
Why?
| | Lipopolysaccharides | 3 | 2025 | 863 | 0.600 |
Why?
| | Assisted Living Facilities | 3 | 2026 | 19 | 0.580 |
Why?
| | Staphylococcal Skin Infections | 2 | 2026 | 41 | 0.570 |
Why?
| | Intimate Partner Violence | 1 | 2020 | 92 | 0.560 |
Why?
| | Tight Junctions | 3 | 2023 | 81 | 0.560 |
Why?
| | Biological Products | 1 | 2022 | 252 | 0.560 |
Why?
| | Genome, Bacterial | 4 | 2025 | 155 | 0.530 |
Why?
| | Autophagy | 3 | 2016 | 286 | 0.530 |
Why?
| | Epithelial Cells | 8 | 2026 | 1125 | 0.530 |
Why?
| | Sepsis | 4 | 2022 | 640 | 0.510 |
Why?
| | Pregnancy Complications, Infectious | 3 | 2019 | 428 | 0.510 |
Why?
| | Resuscitation Orders | 1 | 2017 | 47 | 0.500 |
Why?
| | Oxidoreductases | 2 | 2008 | 96 | 0.500 |
Why?
| | Infant, Newborn | 9 | 2023 | 6429 | 0.500 |
Why?
| | Plasmids | 6 | 2009 | 379 | 0.490 |
Why?
| | Peptides | 2 | 2013 | 995 | 0.490 |
Why?
| | Complement C5a | 2 | 2013 | 54 | 0.480 |
Why?
| | Inflammation | 3 | 2026 | 2878 | 0.480 |
Why?
| | Transcriptional Activation | 1 | 2018 | 383 | 0.480 |
Why?
| | Public Health | 1 | 2021 | 566 | 0.480 |
Why?
| | Workplace | 1 | 2018 | 274 | 0.470 |
Why?
| | Health Behavior | 2 | 2019 | 785 | 0.470 |
Why?
| | Astrocytes | 2 | 2015 | 222 | 0.470 |
Why?
| | Interleukin-8 | 5 | 2015 | 271 | 0.460 |
Why?
| | Mutagenesis | 4 | 2025 | 192 | 0.450 |
Why?
| | Staphylococcal Infections | 4 | 2025 | 388 | 0.440 |
Why?
| | Cells, Cultured | 9 | 2021 | 4154 | 0.430 |
Why?
| | Cell Membrane | 2 | 2010 | 706 | 0.420 |
Why?
| | Diabetes Mellitus | 1 | 2023 | 1098 | 0.410 |
Why?
| | Genitalia, Female | 3 | 2024 | 42 | 0.410 |
Why?
| | Larva | 1 | 2015 | 242 | 0.410 |
Why?
| | Reproductive Tract Infections | 1 | 2013 | 2 | 0.400 |
Why?
| | Neuraminidase | 2 | 2010 | 24 | 0.400 |
Why?
| | Zebrafish | 2 | 2015 | 528 | 0.400 |
Why?
| | MAP Kinase Signaling System | 1 | 2015 | 310 | 0.390 |
Why?
| | Streptococcus pneumoniae | 3 | 2023 | 177 | 0.390 |
Why?
| | Ownership | 2 | 2026 | 111 | 0.380 |
Why?
| | Parasites | 1 | 2013 | 44 | 0.380 |
Why?
| | Gram-Positive Bacteria | 2 | 2023 | 47 | 0.370 |
Why?
| | Gene Expression Profiling | 8 | 2021 | 1782 | 0.360 |
Why?
| | Signal Transduction | 7 | 2015 | 5226 | 0.360 |
Why?
| | Repressor Proteins | 2 | 2013 | 437 | 0.360 |
Why?
| | Integrin alpha2beta1 | 1 | 2011 | 3 | 0.350 |
Why?
| | Health Promotion | 1 | 2018 | 774 | 0.350 |
Why?
| | Health Personnel | 1 | 2018 | 748 | 0.350 |
Why?
| | Mental Disorders | 1 | 2020 | 1168 | 0.340 |
Why?
| | Membrane Glycoproteins | 1 | 2014 | 496 | 0.340 |
Why?
| | Viruses | 1 | 2013 | 165 | 0.330 |
Why?
| | Delay Discounting | 2 | 2022 | 29 | 0.330 |
Why?
| | Anti-Bacterial Agents | 4 | 2021 | 1907 | 0.320 |
Why?
| | DNA Replication | 4 | 1999 | 251 | 0.320 |
Why?
| | Phagocytes | 2 | 2008 | 81 | 0.310 |
Why?
| | Poverty | 4 | 2021 | 529 | 0.300 |
Why?
| | Oligosaccharides | 2 | 2022 | 60 | 0.300 |
Why?
| | Bacteria | 2 | 2013 | 889 | 0.300 |
Why?
| | Immunologic Factors | 1 | 2011 | 255 | 0.300 |
Why?
| | Microcirculation | 2 | 2011 | 138 | 0.290 |
Why?
| | Medically Underserved Area | 2 | 2020 | 101 | 0.290 |
Why?
| | Attitude of Health Personnel | 1 | 2017 | 1185 | 0.290 |
Why?
| | Immunity, Innate | 3 | 2016 | 846 | 0.280 |
Why?
| | HIV Infections | 2 | 2020 | 3154 | 0.270 |
Why?
| | Mice, Inbred C57BL | 9 | 2026 | 5992 | 0.270 |
Why?
| | Escherichia coli | 5 | 2013 | 854 | 0.260 |
Why?
| | Intestinal Mucosa | 1 | 2013 | 676 | 0.260 |
Why?
| | Operon | 2 | 2023 | 69 | 0.260 |
Why?
| | Transcription Factors | 2 | 2015 | 1741 | 0.260 |
Why?
| | Carrier State | 2 | 2026 | 79 | 0.250 |
Why?
| | Mice, Knockout | 6 | 2026 | 3121 | 0.250 |
Why?
| | DNA Restriction-Modification Enzymes | 1 | 2026 | 3 | 0.250 |
Why?
| | Genomics | 3 | 2022 | 834 | 0.250 |
Why?
| | Substance-Related Disorders | 3 | 2020 | 1094 | 0.250 |
Why?
| | Baltimore | 3 | 2020 | 71 | 0.240 |
Why?
| | Cardiovascular Diseases | 1 | 2018 | 2168 | 0.230 |
Why?
| | Animals, Newborn | 3 | 2026 | 902 | 0.230 |
Why?
| | Cerebrovascular Circulation | 1 | 2008 | 280 | 0.230 |
Why?
| | Enzyme-Linked Immunosorbent Assay | 3 | 2015 | 851 | 0.230 |
Why?
| | Serotyping | 2 | 2019 | 32 | 0.230 |
Why?
| | Probiotics | 1 | 2026 | 61 | 0.230 |
Why?
| | Adult | 12 | 2026 | 40449 | 0.230 |
Why?
| | Helicobacter Infections | 2 | 2017 | 30 | 0.230 |
Why?
| | Toll-Like Receptor 2 | 1 | 2026 | 126 | 0.230 |
Why?
| | Perception | 2 | 2018 | 377 | 0.220 |
Why?
| | Mice, Inbred BALB C | 3 | 2019 | 1253 | 0.220 |
Why?
| | Uterus | 1 | 2026 | 226 | 0.220 |
Why?
| | Arginine | 1 | 2026 | 262 | 0.220 |
Why?
| | Replication Origin | 3 | 1999 | 21 | 0.210 |
Why?
| | Myeloid Differentiation Factor 88 | 2 | 2017 | 114 | 0.210 |
Why?
| | Coinfection | 1 | 2026 | 141 | 0.210 |
Why?
| | DNA-Binding Proteins | 4 | 1999 | 1499 | 0.210 |
Why?
| | DNA, Bacterial | 5 | 2004 | 342 | 0.210 |
Why?
| | DNA Transposable Elements | 1 | 2025 | 122 | 0.210 |
Why?
| | Cross-Sectional Studies | 4 | 2026 | 5868 | 0.210 |
Why?
| | DNA-Cytosine Methylases | 1 | 2023 | 3 | 0.210 |
Why?
| | Nursing Homes | 1 | 2026 | 172 | 0.200 |
Why?
| | Biological Transport | 3 | 2022 | 417 | 0.200 |
Why?
| | Stomach Neoplasms | 2 | 2017 | 126 | 0.200 |
Why?
| | Colony Count, Microbial | 2 | 2014 | 122 | 0.200 |
Why?
| | Zonula Occludens-1 Protein | 2 | 2015 | 16 | 0.200 |
Why?
| | Male | 17 | 2026 | 72315 | 0.200 |
Why?
| | Case Management | 2 | 2020 | 67 | 0.200 |
Why?
| | Receptors, Interleukin-8B | 2 | 2013 | 23 | 0.200 |
Why?
| | Collagen | 1 | 2026 | 456 | 0.190 |
Why?
| | Gastrointestinal Tract | 1 | 2026 | 208 | 0.190 |
Why?
| | Pain | 2 | 2026 | 779 | 0.190 |
Why?
| | HeLa Cells | 3 | 2021 | 650 | 0.190 |
Why?
| | Keratin-19 | 1 | 2022 | 4 | 0.190 |
Why?
| | Neuroimmunomodulation | 1 | 2023 | 68 | 0.190 |
Why?
| | Self Efficacy | 1 | 2026 | 414 | 0.190 |
Why?
| | Coxsackievirus Infections | 2 | 2013 | 14 | 0.180 |
Why?
| | Paraquat | 1 | 2022 | 13 | 0.180 |
Why?
| | Bacteremia | 1 | 2025 | 221 | 0.180 |
Why?
| | Meningitis | 2 | 2022 | 80 | 0.180 |
Why?
| | RNA, Bacterial | 2 | 2021 | 189 | 0.180 |
Why?
| | RNA, Small Untranslated | 1 | 2021 | 14 | 0.180 |
Why?
| | Dementia | 1 | 2026 | 303 | 0.180 |
Why?
| | Mucins | 1 | 2022 | 76 | 0.170 |
Why?
| | Diseases in Twins | 1 | 2002 | 115 | 0.170 |
Why?
| | Learning | 3 | 2022 | 452 | 0.170 |
Why?
| | Long-Term Care | 2 | 2020 | 117 | 0.170 |
Why?
| | Amino Acid Sequence | 4 | 2015 | 2155 | 0.170 |
Why?
| | Glycoproteins | 2 | 2013 | 355 | 0.170 |
Why?
| | Carcinoembryonic Antigen | 1 | 2021 | 38 | 0.170 |
Why?
| | Ethanolamine | 1 | 2020 | 6 | 0.170 |
Why?
| | beta Catenin | 1 | 2023 | 252 | 0.160 |
Why?
| | Chemotaxis, Leukocyte | 2 | 2011 | 113 | 0.160 |
Why?
| | Memory, Short-Term | 2 | 2022 | 271 | 0.160 |
Why?
| | Cigarette Smoking | 1 | 2022 | 99 | 0.160 |
Why?
| | Hydrogen Peroxide | 1 | 2022 | 336 | 0.160 |
Why?
| | Nursing Staff | 1 | 2020 | 41 | 0.160 |
Why?
| | Transcription, Genetic | 3 | 2023 | 1496 | 0.160 |
Why?
| | Community Medicine | 1 | 2020 | 7 | 0.160 |
Why?
| | Escherichia coli Proteins | 2 | 1999 | 206 | 0.160 |
Why?
| | Nurse-Patient Relations | 1 | 2020 | 66 | 0.160 |
Why?
| | Reverse Transcriptase Polymerase Chain Reaction | 3 | 2015 | 983 | 0.160 |
Why?
| | Fluorescent Antibody Technique | 3 | 2016 | 370 | 0.150 |
Why?
| | Cell Adhesion Molecules | 1 | 2021 | 178 | 0.150 |
Why?
| | Drug Resistance, Microbial | 1 | 2019 | 69 | 0.150 |
Why?
| | Cytokines | 2 | 2026 | 2061 | 0.150 |
Why?
| | Disease Susceptibility | 1 | 2021 | 348 | 0.150 |
Why?
| | Michigan | 1 | 2019 | 136 | 0.150 |
Why?
| | South Africa | 1 | 2020 | 261 | 0.150 |
Why?
| | Mucin-5B | 1 | 2022 | 234 | 0.150 |
Why?
| | Molecular Sequence Data | 4 | 2015 | 2930 | 0.150 |
Why?
| | Naloxone | 1 | 2020 | 132 | 0.150 |
Why?
| | Students, Nursing | 1 | 2020 | 90 | 0.140 |
Why?
| | Mice, Mutant Strains | 1 | 2019 | 299 | 0.140 |
Why?
| | Sexual Partners | 1 | 2020 | 192 | 0.140 |
Why?
| | Risk Factors | 4 | 2020 | 10779 | 0.140 |
Why?
| | Vaginosis, Bacterial | 1 | 2018 | 10 | 0.140 |
Why?
| | Phagocytosis | 2 | 2026 | 299 | 0.140 |
Why?
| | Narcotic Antagonists | 1 | 2020 | 205 | 0.140 |
Why?
| | Homeostasis | 1 | 2022 | 640 | 0.140 |
Why?
| | Empathy | 1 | 2020 | 182 | 0.140 |
Why?
| | Students, Health Occupations | 1 | 2018 | 37 | 0.140 |
Why?
| | Antigens, CD | 1 | 2021 | 555 | 0.130 |
Why?
| | Neonatology | 1 | 2018 | 28 | 0.130 |
Why?
| | Helicobacter pylori | 2 | 2017 | 45 | 0.130 |
Why?
| | Ireland | 1 | 2017 | 32 | 0.130 |
Why?
| | Macrophages | 5 | 2026 | 1511 | 0.130 |
Why?
| | Sequence Analysis, RNA | 1 | 2019 | 442 | 0.130 |
Why?
| | Iron | 1 | 2019 | 359 | 0.130 |
Why?
| | Geriatrics | 1 | 2018 | 96 | 0.130 |
Why?
| | Central Nervous System | 2 | 2023 | 281 | 0.130 |
Why?
| | Outpatients | 1 | 2020 | 442 | 0.120 |
Why?
| | Choroid Plexus | 2 | 2013 | 5 | 0.120 |
Why?
| | Serine Endopeptidases | 1 | 2017 | 128 | 0.120 |
Why?
| | Patient Selection | 1 | 2021 | 719 | 0.120 |
Why?
| | Behavior Therapy | 1 | 2020 | 299 | 0.120 |
Why?
| | Polymerase Chain Reaction | 2 | 2010 | 1054 | 0.120 |
Why?
| | Microtubule-Associated Proteins | 2 | 2014 | 196 | 0.120 |
Why?
| | N-Acetylmuramoyl-L-alanine Amidase | 1 | 2016 | 5 | 0.120 |
Why?
| | Sheep | 1 | 2019 | 880 | 0.120 |
Why?
| | Cell Movement | 2 | 2016 | 965 | 0.120 |
Why?
| | Urban Population | 1 | 2019 | 491 | 0.120 |
Why?
| | Genes, Regulator | 1 | 2016 | 35 | 0.120 |
Why?
| | Induced Pluripotent Stem Cells | 1 | 2019 | 276 | 0.120 |
Why?
| | Informed Consent | 1 | 2018 | 198 | 0.120 |
Why?
| | Organelle Biogenesis | 1 | 2016 | 15 | 0.120 |
Why?
| | Mast Cells | 1 | 2017 | 146 | 0.120 |
Why?
| | Drug Overdose | 1 | 2020 | 370 | 0.120 |
Why?
| | Claudin-5 | 1 | 2015 | 3 | 0.110 |
Why?
| | Snail Family Transcription Factors | 1 | 2015 | 18 | 0.110 |
Why?
| | Patient-Centered Care | 1 | 2020 | 544 | 0.110 |
Why?
| | Myoblasts | 1 | 2016 | 84 | 0.110 |
Why?
| | Cooperative Behavior | 1 | 2018 | 465 | 0.110 |
Why?
| | Biological Assay | 1 | 2016 | 128 | 0.110 |
Why?
| | Muscle Development | 1 | 2016 | 116 | 0.110 |
Why?
| | Protein Binding | 5 | 2026 | 2273 | 0.110 |
Why?
| | Mitogen-Activated Protein Kinase 3 | 1 | 2015 | 138 | 0.110 |
Why?
| | Research | 1 | 2018 | 431 | 0.110 |
Why?
| | Coculture Techniques | 1 | 2015 | 246 | 0.110 |
Why?
| | Mitogen-Activated Protein Kinase 1 | 1 | 2015 | 175 | 0.110 |
Why?
| | Enterovirus B, Human | 1 | 2014 | 25 | 0.110 |
Why?
| | Gene Regulatory Networks | 1 | 2017 | 318 | 0.110 |
Why?
| | Young Adult | 3 | 2021 | 14105 | 0.100 |
Why?
| | Phagosomes | 1 | 2014 | 40 | 0.100 |
Why?
| | Vaginal Diseases | 1 | 2014 | 18 | 0.100 |
Why?
| | Exercise | 1 | 2026 | 2201 | 0.100 |
Why?
| | Virus Shedding | 1 | 2014 | 48 | 0.100 |
Why?
| | Lymphocytic Choriomeningitis | 1 | 2013 | 25 | 0.100 |
Why?
| | Genetic Fitness | 1 | 2014 | 59 | 0.100 |
Why?
| | Integrins | 1 | 2014 | 89 | 0.100 |
Why?
| | Survival Analysis | 2 | 2015 | 1382 | 0.100 |
Why?
| | Immunologic Deficiency Syndromes | 1 | 2013 | 65 | 0.100 |
Why?
| | Serine | 1 | 2014 | 145 | 0.100 |
Why?
| | Recombinant Fusion Proteins | 1 | 2016 | 675 | 0.100 |
Why?
| | Receptor, Anaphylatoxin C5a | 1 | 2013 | 35 | 0.100 |
Why?
| | Bacterial Translocation | 1 | 2013 | 52 | 0.100 |
Why?
| | Cell-Derived Microparticles | 1 | 2014 | 75 | 0.100 |
Why?
| | Protein Transport | 1 | 2014 | 441 | 0.100 |
Why?
| | Epithelium | 1 | 2014 | 314 | 0.100 |
Why?
| | Sequence Alignment | 2 | 2015 | 366 | 0.090 |
Why?
| | Interleukin-1beta | 1 | 2015 | 395 | 0.090 |
Why?
| | Mucus | 1 | 2013 | 73 | 0.090 |
Why?
| | Blotting, Western | 1 | 2015 | 1187 | 0.090 |
Why?
| | Aged | 4 | 2026 | 25913 | 0.090 |
Why?
| | Quality Improvement | 1 | 2021 | 1289 | 0.090 |
Why?
| | Anxiety | 1 | 2020 | 1109 | 0.090 |
Why?
| | Species Specificity | 1 | 2013 | 574 | 0.090 |
Why?
| | Middle Aged | 6 | 2026 | 35875 | 0.090 |
Why?
| | Arylsulfotransferase | 1 | 2011 | 3 | 0.090 |
Why?
| | Neural Stem Cells | 1 | 2013 | 166 | 0.090 |
Why?
| | Zebrafish Proteins | 1 | 2015 | 311 | 0.090 |
Why?
| | Phosphoprotein Phosphatases | 1 | 2011 | 65 | 0.090 |
Why?
| | Focal Adhesion Protein-Tyrosine Kinases | 1 | 2011 | 35 | 0.090 |
Why?
| | Bacterial Physiological Phenomena | 1 | 2012 | 60 | 0.090 |
Why?
| | Enterovirus Infections | 1 | 2014 | 173 | 0.090 |
Why?
| | DNA Primers | 2 | 2009 | 512 | 0.090 |
Why?
| | Oligonucleotide Array Sequence Analysis | 2 | 2010 | 758 | 0.090 |
Why?
| | Bacteriophages | 1 | 2013 | 111 | 0.090 |
Why?
| | Medicaid | 1 | 2015 | 461 | 0.080 |
Why?
| | Cathelicidins | 2 | 2008 | 41 | 0.080 |
Why?
| | Flow Cytometry | 1 | 2015 | 1173 | 0.080 |
Why?
| | Immunohistochemistry | 1 | 2015 | 1716 | 0.080 |
Why?
| | Lung | 2 | 2017 | 4109 | 0.080 |
Why?
| | Chemokine CCL20 | 1 | 2010 | 5 | 0.080 |
Why?
| | Chemokine CXCL2 | 1 | 2010 | 41 | 0.080 |
Why?
| | Antimicrobial Cationic Peptides | 2 | 2008 | 86 | 0.080 |
Why?
| | Chemokine CXCL1 | 1 | 2010 | 76 | 0.080 |
Why?
| | Lectins | 1 | 2010 | 44 | 0.080 |
Why?
| | Brazil | 2 | 2021 | 180 | 0.080 |
Why?
| | Neutrophil Infiltration | 1 | 2010 | 104 | 0.080 |
Why?
| | Biomarkers | 1 | 2021 | 4271 | 0.080 |
Why?
| | Cell Wall | 1 | 2010 | 61 | 0.080 |
Why?
| | Microvessels | 1 | 2011 | 99 | 0.080 |
Why?
| | Binding Sites | 4 | 2021 | 1329 | 0.080 |
Why?
| | Biomarkers, Tumor | 1 | 2017 | 1313 | 0.080 |
Why?
| | Bacterial Capsules | 2 | 2026 | 33 | 0.070 |
Why?
| | Mice, Transgenic | 1 | 2014 | 2182 | 0.070 |
Why?
| | Physicians | 1 | 2018 | 939 | 0.070 |
Why?
| | Myeloid Cells | 1 | 2010 | 148 | 0.070 |
Why?
| | Parents | 1 | 2018 | 1403 | 0.070 |
Why?
| | Salmonella typhimurium | 1 | 2010 | 190 | 0.070 |
Why?
| | Blindness | 1 | 2009 | 52 | 0.070 |
Why?
| | Placenta | 2 | 2013 | 780 | 0.070 |
Why?
| | Phosphoproteins | 1 | 2011 | 344 | 0.070 |
Why?
| | Gene Expression | 1 | 2013 | 1490 | 0.070 |
Why?
| | Lactococcus lactis | 1 | 2008 | 2 | 0.070 |
Why?
| | Microscopy | 1 | 2009 | 156 | 0.070 |
Why?
| | Deafness | 1 | 2009 | 78 | 0.070 |
Why?
| | Cell Differentiation | 1 | 2016 | 2050 | 0.070 |
Why?
| | Peer Group | 2 | 2020 | 257 | 0.070 |
Why?
| | Macrophages, Peritoneal | 1 | 2008 | 89 | 0.070 |
Why?
| | Surveys and Questionnaires | 2 | 2018 | 6048 | 0.070 |
Why?
| | Streptolysins | 1 | 2006 | 11 | 0.060 |
Why?
| | Cerebral Palsy | 1 | 2009 | 132 | 0.060 |
Why?
| | Streptococcus pyogenes | 1 | 2006 | 41 | 0.060 |
Why?
| | Drug Resistance, Bacterial | 1 | 2008 | 196 | 0.060 |
Why?
| | Models, Neurological | 1 | 2008 | 254 | 0.060 |
Why?
| | Adolescent | 3 | 2021 | 22428 | 0.060 |
Why?
| | Trophoblasts | 1 | 2008 | 216 | 0.060 |
Why?
| | Seizures | 1 | 2009 | 460 | 0.060 |
Why?
| | Neoplasms | 1 | 2021 | 2875 | 0.060 |
Why?
| | Cognition Disorders | 1 | 2009 | 538 | 0.050 |
Why?
| | Cytotoxins | 1 | 2004 | 16 | 0.050 |
Why?
| | Carotenoids | 1 | 2004 | 48 | 0.050 |
Why?
| | Membrane Proteins | 1 | 2011 | 1166 | 0.050 |
Why?
| | Child | 2 | 2020 | 22633 | 0.050 |
Why?
| | Receptor Activity-Modifying Protein 1 | 1 | 2023 | 2 | 0.050 |
Why?
| | Arachnoid | 1 | 2023 | 11 | 0.050 |
Why?
| | Emergency Service, Hospital | 1 | 2015 | 2310 | 0.050 |
Why?
| | NAV1.8 Voltage-Gated Sodium Channel | 1 | 2023 | 3 | 0.050 |
Why?
| | Nociceptors | 1 | 2023 | 41 | 0.050 |
Why?
| | Calcitonin Gene-Related Peptide | 1 | 2023 | 40 | 0.050 |
Why?
| | DNA Footprinting | 2 | 1999 | 33 | 0.050 |
Why?
| | Aminoacyltransferases | 1 | 2022 | 5 | 0.050 |
Why?
| | 1,2-Dipalmitoylphosphatidylcholine | 1 | 2002 | 9 | 0.050 |
Why?
| | Fibronectins | 1 | 2022 | 136 | 0.050 |
Why?
| | Pain Management | 1 | 2026 | 405 | 0.040 |
Why?
| | Cations | 1 | 2022 | 82 | 0.040 |
Why?
| | Twins, Monozygotic | 1 | 2002 | 134 | 0.040 |
Why?
| | Fatal Outcome | 1 | 2002 | 307 | 0.040 |
Why?
| | Spectrometry, Mass, Electrospray Ionization | 1 | 2022 | 179 | 0.040 |
Why?
| | DNA Methylation | 1 | 2026 | 681 | 0.040 |
Why?
| | Aged, 80 and over | 2 | 2026 | 8265 | 0.040 |
Why?
| | Cricetulus | 1 | 2021 | 118 | 0.040 |
Why?
| | CHO Cells | 1 | 2021 | 171 | 0.040 |
Why?
| | GPI-Linked Proteins | 1 | 2021 | 80 | 0.040 |
Why?
| | Treatment Outcome | 2 | 2016 | 11679 | 0.040 |
Why?
| | Cricetinae | 1 | 2021 | 303 | 0.040 |
Why?
| | RNA Stability | 1 | 2021 | 119 | 0.040 |
Why?
| | Drug Resistance, Multiple, Bacterial | 1 | 2021 | 81 | 0.040 |
Why?
| | Age of Onset | 1 | 2002 | 551 | 0.040 |
Why?
| | Chromatography, Liquid | 1 | 2022 | 454 | 0.040 |
Why?
| | Cognitive Remediation | 1 | 2019 | 4 | 0.040 |
Why?
| | Reward | 1 | 2022 | 247 | 0.040 |
Why?
| | Protein Conformation | 2 | 2013 | 946 | 0.040 |
Why?
| | Mutagenesis, Site-Directed | 2 | 2013 | 381 | 0.040 |
Why?
| | Molecular Sequence Annotation | 1 | 2020 | 105 | 0.040 |
Why?
| | Transformation, Genetic | 1 | 1999 | 15 | 0.040 |
Why?
| | Public Health Surveillance | 1 | 2020 | 83 | 0.040 |
Why?
| | Microbial Sensitivity Tests | 1 | 2021 | 370 | 0.040 |
Why?
| | Regulatory Sequences, Nucleic Acid | 1 | 1999 | 96 | 0.040 |
Why?
| | Community Pharmacy Services | 1 | 1999 | 46 | 0.040 |
Why?
| | Drug Therapy | 1 | 1999 | 80 | 0.040 |
Why?
| | Phosphorylation | 2 | 2015 | 1732 | 0.040 |
Why?
| | Residential Facilities | 1 | 2018 | 8 | 0.040 |
Why?
| | Tandem Mass Spectrometry | 1 | 2022 | 576 | 0.040 |
Why?
| | Carrier Proteins | 1 | 2022 | 737 | 0.040 |
Why?
| | Sequence Analysis | 1 | 1998 | 35 | 0.030 |
Why?
| | Pharmaceutical Preparations | 1 | 2020 | 170 | 0.030 |
Why?
| | Models, Molecular | 2 | 2013 | 1618 | 0.030 |
Why?
| | DNA Helicases | 1 | 1999 | 143 | 0.030 |
Why?
| | Chymases | 1 | 2017 | 8 | 0.030 |
Why?
| | Enzyme Activation | 1 | 1999 | 766 | 0.030 |
Why?
| | Disease Progression | 2 | 2017 | 2847 | 0.030 |
Why?
| | Writing | 1 | 2018 | 100 | 0.030 |
Why?
| | Anxiety Disorders | 1 | 2020 | 373 | 0.030 |
Why?
| | Mastitis | 1 | 2016 | 6 | 0.030 |
Why?
| | Genotype | 1 | 2021 | 1833 | 0.030 |
Why?
| | Family Practice | 1 | 1999 | 404 | 0.030 |
Why?
| | Macrolides | 1 | 2016 | 69 | 0.030 |
Why?
| | Phylogeny | 1 | 2020 | 1016 | 0.030 |
Why?
| | Rats | 2 | 2016 | 5597 | 0.030 |
Why?
| | Histidine Kinase | 1 | 2015 | 34 | 0.030 |
Why?
| | Computational Biology | 1 | 2020 | 680 | 0.030 |
Why?
| | Oxidative Phosphorylation | 1 | 2016 | 210 | 0.030 |
Why?
| | Education, Medical | 1 | 2018 | 274 | 0.030 |
Why?
| | Emotions | 1 | 2020 | 578 | 0.030 |
Why?
| | Muscle Fibers, Skeletal | 1 | 2016 | 214 | 0.030 |
Why?
| | Mice, Inbred Strains | 1 | 2015 | 397 | 0.030 |
Why?
| | Carbonic Anhydrase II | 1 | 2013 | 4 | 0.030 |
Why?
| | Communication | 1 | 2020 | 965 | 0.030 |
Why?
| | Osteomyelitis | 1 | 2016 | 143 | 0.030 |
Why?
| | Nestin | 1 | 2013 | 19 | 0.030 |
Why?
| | United States | 2 | 2026 | 15966 | 0.030 |
Why?
| | Health Care Surveys | 1 | 2015 | 539 | 0.030 |
Why?
| | Microarray Analysis | 1 | 2013 | 117 | 0.030 |
Why?
| | Gastric Mucosa | 1 | 2013 | 52 | 0.030 |
Why?
| | Adhesiveness | 1 | 2013 | 18 | 0.020 |
Why?
| | Bacteriophage T4 | 1 | 2013 | 18 | 0.020 |
Why?
| | Social Support | 1 | 2018 | 652 | 0.020 |
Why?
| | Protein Interaction Domains and Motifs | 1 | 2014 | 148 | 0.020 |
Why?
| | Chronic Disease | 1 | 2019 | 1813 | 0.020 |
Why?
| | X-Ray Diffraction | 1 | 2013 | 103 | 0.020 |
Why?
| | Models, Immunological | 1 | 2013 | 100 | 0.020 |
Why?
| | Carbon | 1 | 2014 | 203 | 0.020 |
Why?
| | Substrate Specificity | 1 | 2013 | 388 | 0.020 |
Why?
| | Sequence Analysis, Protein | 1 | 2012 | 33 | 0.020 |
Why?
| | Phenotype | 2 | 2014 | 3162 | 0.020 |
Why?
| | Cluster Analysis | 1 | 2014 | 521 | 0.020 |
Why?
| | Symbiosis | 1 | 2013 | 81 | 0.020 |
Why?
| | Precancerous Conditions | 1 | 2013 | 166 | 0.020 |
Why?
| | Decision Making | 1 | 2019 | 975 | 0.020 |
Why?
| | Extracellular Matrix Proteins | 1 | 2013 | 158 | 0.020 |
Why?
| | Case-Control Studies | 1 | 2019 | 3604 | 0.020 |
Why?
| | Randomized Controlled Trials as Topic | 1 | 2018 | 1720 | 0.020 |
Why?
| | Viral Proteins | 1 | 2014 | 355 | 0.020 |
Why?
| | Protein Structure, Tertiary | 1 | 2013 | 862 | 0.020 |
Why?
| | Computer Simulation | 1 | 2016 | 1025 | 0.020 |
Why?
| | Apoptosis | 2 | 2013 | 2430 | 0.020 |
Why?
| | RNA Processing, Post-Transcriptional | 1 | 2011 | 92 | 0.020 |
Why?
| | Cell Death | 1 | 2012 | 383 | 0.020 |
Why?
| | Tumor Cells, Cultured | 1 | 2012 | 919 | 0.020 |
Why?
| | Qualitative Research | 1 | 2018 | 1671 | 0.020 |
Why?
| | Promoter Regions, Genetic | 1 | 2015 | 1257 | 0.020 |
Why?
| | In Situ Hybridization | 1 | 2010 | 319 | 0.020 |
Why?
| | N-Acetylneuraminic Acid | 1 | 2009 | 16 | 0.020 |
Why?
| | Microscopy, Confocal | 1 | 2010 | 321 | 0.020 |
Why?
| | Mitochondria | 1 | 2016 | 984 | 0.020 |
Why?
| | Streptococcal Vaccines | 1 | 2008 | 7 | 0.020 |
Why?
| | Models, Biological | 1 | 2016 | 1821 | 0.020 |
Why?
| | Cell Adhesion | 1 | 2009 | 455 | 0.020 |
Why?
| | Infant | 1 | 2002 | 10034 | 0.020 |
Why?
| | Base Sequence | 2 | 2004 | 2190 | 0.020 |
Why?
| | Genetic Complementation Test | 1 | 2007 | 66 | 0.020 |
Why?
| | Protein Processing, Post-Translational | 1 | 2010 | 477 | 0.020 |
Why?
| | Cysteine Endopeptidases | 1 | 2006 | 73 | 0.020 |
Why?
| | Culture Media | 1 | 2006 | 161 | 0.020 |
Why?
| | Cell Proliferation | 1 | 2013 | 2496 | 0.010 |
Why?
| | Stem Cells | 1 | 2010 | 626 | 0.010 |
Why?
| | Child, Preschool | 1 | 2020 | 11787 | 0.010 |
Why?
| | Hyaluronic Acid | 1 | 2006 | 208 | 0.010 |
Why?
| | Proteomics | 1 | 2011 | 1195 | 0.010 |
Why?
| | Cell Line, Tumor | 1 | 2012 | 3540 | 0.010 |
Why?
| | Genes, Bacterial | 1 | 2004 | 166 | 0.010 |
Why?
| | Cell Survival | 1 | 2006 | 1098 | 0.010 |
Why?
| | Biomedical Research | 1 | 2008 | 710 | 0.010 |
Why?
| | Reactive Oxygen Species | 1 | 2004 | 621 | 0.010 |
Why?
| | Neurons | 1 | 2010 | 1640 | 0.010 |
Why?
| | Evaluation Studies as Topic | 1 | 1999 | 166 | 0.010 |
Why?
| | England | 1 | 1999 | 111 | 0.010 |
Why?
| | Professional Practice | 1 | 1999 | 57 | 0.010 |
Why?
| | Costs and Cost Analysis | 1 | 1999 | 219 | 0.010 |
Why?
| | Chromosome Mapping | 1 | 1997 | 510 | 0.010 |
Why?
| | Time Factors | 1 | 2007 | 7173 | 0.010 |
Why?
| | Adenosine Triphosphate | 1 | 1997 | 498 | 0.010 |
Why?
|
|
Doran's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts  Derived automatically from this person's publications. _
Co-Authors  People in Profiles who have published with this person. _
Similar People  People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
Physical Neighbors  People whose addresses are nearby this person. _
|